Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Research Award: Canada Graduate Scholarships

McMaster University

$120,000.00

Investigating Genetic and Transcriptional Programming of Tumour-Associated Macrophages in Glioblastoma

EF 2024-25

Résumé
Glioblastoma (GBM) is an aggressive brain cancer with a very poor prognosis, where only 4% of patients survive beyond five years. Cancer Stem Cells (CSCs) are a small population of GBM cells that resemble normal stem cells and contribute to high genetic diversity of the tumour, making GBM very difficult to treat. CSCs form important interactions with other cancer cells, but also with non-cancerous cells present around the tumour. The predominant non-cancerous cell in GBM are macrophages, immune cells responsible for engulfing and clearing bacteria, debris, or stressed cells, including cancer cells. Interestingly, despite accounting for up to half of the tumour mass, macrophages do not function as immune defenders in GBM. Instead, they support cancer growth. This study aims to understand how CSCs and macrophages communicate with each other, and importantly, how to turn macrophages into potent anti-tumour effectors capable of eliminating cancer cells. We will first culture CSCs and macrophages isolated from patient tumours collected at the time of surgery, then analyze changes in their gene expression after co-culture. This analysis helps us understand how CSCs and macrophages communicate with each other. Secondly, we will use the gene editing tool CRISPR/Cas9 to determine which genes in macrophages are involved in tumour engulfment and clearance. This will be done by systematically inactivating each of the ~20,000 genes in the genome in a population of macrophages, then mixing them with glioblastoma cells. Afterwards, we will separate the two populations again, and harvest the macrophages that engulfed tumour cells to find out which genes, when deactivated, promote tumour cell clearance. By combining these approaches, we hope to reveal new insights into the CSC-macrophage interaction at the molecular level. These findings will lead to new treatments that enable the immune system to better recognize and eliminate GBM, offering hope for more effective therapies.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
518230
Name
Grewal Shan
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Investigating Genetic and Transcriptional Programming of Tumour-Associated Macrophages in Glioblastoma
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Cancer Immunology; Cancer Stem Cells; Glioblastoma; Immunotherapy; Tumour-Associated Macrophages
Abstract
Glioblastoma (GBM) is an aggressive brain cancer with a very poor prognosis, where only 4% of patients survive beyond five years. Cancer Stem Cells (CSCs) are a small population of GBM cells that resemble normal stem cells and contribute to high genetic diversity of the tumour, making GBM very difficult to treat. CSCs form important interactions with other cancer cells, but also with non-cancerous cells present around the tumour. The predominant non-cancerous cell in GBM are macrophages, immune cells responsible for engulfing and clearing bacteria, debris, or stressed cells, including cancer cells. Interestingly, despite accounting for up to half of the tumour mass, macrophages do not function as immune defenders in GBM. Instead, they support cancer growth. This study aims to understand how CSCs and macrophages communicate with each other, and importantly, how to turn macrophages into potent anti-tumour effectors capable of eliminating cancer cells. We will first culture CSCs and macrophages isolated from patient tumours collected at the time of surgery, then analyze changes in their gene expression after co-culture. This analysis helps us understand how CSCs and macrophages communicate with each other. Secondly, we will use the gene editing tool CRISPR/Cas9 to determine which genes in macrophages are involved in tumour engulfment and clearance. This will be done by systematically inactivating each of the ~20,000 genes in the genome in a population of macrophages, then mixing them with glioblastoma cells. Afterwards, we will separate the two populations again, and harvest the macrophages that engulfed tumour cells to find out which genes, when deactivated, promote tumour cell clearance. By combining these approaches, we hope to reveal new insights into the CSC-macrophage interaction at the molecular level. These findings will lead to new treatments that enable the immune system to better recognize and eliminate GBM, offering hope for more effective therapies.
Competitiondate
202411
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Grewal, Shan
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~